Clinical Trials Browser

OTHER × Prostate Adenocarcinoma × fluciclovine F-18 × Clear all

NCT03762759 2024-05-17

Fluciclovine F18 or Ga68-PSMA PET/CT to Enhance Prostate Cancer Outcomes

Phase 2 Unknown

Prostate Adenocarcinoma